HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mertens, W. C. Articles by Porter, A. T. Search for Related Content PubMed PubMed Citation Articles by Mertens, W. C. Articles by Porter, A. T.

CA: A Cancer Journal for Clinicians, Vol 48, Issue 6 361-374, Copyright © 1998 by American Cancer Society

ARTICLES

Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current concepts

W. C. Mertens, L. A. Filipczak, E. Ben-Josef, L. P. Davis and A. T. Porter
Oncology Services, North Oakland Medical Centers, Pontiac, MI, USA.

Bone metastases require multidisciplinary treatment, the primary goal of which is to relieve pain and improve quality of life. Among the options available, bone-seeking radioisotopes are attractive because they can treat several symptomatic metastases simultaneously. This therapy may have antitumor efficacy in addition to analgesic properties. Although the ultimate place of systemic radionuclides in the treatment of bone metastases has not been firmly established, some patients clearly benefit from these modalities.

This article has been cited by other articles:

				G. M. Reisfield, E. B. Silberstein, and G. R. Wilson Radiopharmaceuticals for the palliation of painful bone metastases American Journal of Hospice and Palliative Medicine, January 1, 2005; 22(1): 41 - 46. [Abstract] [PDF]